Breast cancer is the most common cancer among Filipino women. It is also one of the most expensive to treat. For years, the gap between what treatment actually costs and what PhilHealth covered was wide enough that many patients abandoned care entirely or delayed it until the disease had progressed beyond control.

That gap has now narrowed significantly. Effective March 30, 2024, PhilHealth’s Z Benefit Package for breast cancer was raised to PHP 1.4 million, a 1,400% increase from the previous package of PHP 100,000. The increase is formalized under PhilHealth Circular 2024-0007.

Why the Old Package Was Not Enough

The previous PHP 100,000 Z Benefit for breast cancer was so inadequate that PhilHealth President and CEO Emmanuel R. Ledesma Jr. acknowledged it was being “laughed at” by some government officials. For context, targeted therapy alone, which is a standard treatment component for certain breast cancer subtypes, can cost over PHP 1 million for a full course. The old package barely covered diagnostics and a portion of surgical costs, leaving patients to shoulder the rest out of pocket.

This matters enormously in the Philippine context. The Philippines has the highest breast cancer mortality rate in Asia and one of the lowest survival rates. Filipino women with breast cancer have a five-year survival rate of around 49.5%, compared to 82.2% for Filipino women living in the United States. A major reason for this disparity is late-stage diagnosis and inability to complete treatment due to cost.

According to the International Agency for Research on Cancer, 1 in 13 Filipino women is expected to develop breast cancer in her lifetime, with an age-standardized rate of 47 per 100,000 women. The Philippines has one of the highest breast cancer mortality rates and the lowest mortality-to-incidence ratios in Asia, with 53% of breast cancers diagnosed at Stages III and IV.

Late-stage presentation is not simply a matter of awareness. Only 1% of Filipino women were tested for breast or cervical cancer in 2023, according to PIDS data, while an estimated 32 Filipino women with breast cancer die every day. 

What the Enhanced Package Actually Covers

The PHP 1.4 million Z Benefit Package is structured around the full continuum of breast cancer care, from diagnosis through post-treatment surveillance.

Under the guidelines of PhilHealth Circular 2024-0007, mandatory services and their corresponding coverage rates are as follows:

Diagnostic tests and prognostication are covered at PHP 1,000 to PHP 10,000. Surgical procedures ranging from partial mastectomy to modified radical mastectomy are covered at PHP 30,000 to PHP 140,000. Hormonotherapy is covered at PHP 2,700 or PHP 18,000 depending on the regimen. Cytotoxic chemotherapy is covered from PHP 43,000 to PHP 185,010. Targeted therapy receives the largest allocation at more than PHP 1 million, translating to PHP 333,336 per cycle for a maximum of 18 cycles. Post-treatment surveillance is covered at PHP 5,000 for basic services and PHP 9,000 for specific services.

The package now covers all stages of breast cancer, from Stage 0 to Stage 4. Critically, eligibility has also been extended to patients who are already undergoing treatment at the time of enrollment, a significant change from the previous package which had more restrictive entry criteria.

No Co-Payment for Ward Accommodation

PhilHealth has specified that no co-payment shall be charged for services rendered to patients admitted in basic or ward-type accommodation. This is a meaningful protection for lower-income patients who cannot afford private room upgrades.

Co-payments may still apply for patients who opt for amenities or services beyond what the package covers, but these are capped and cannot exceed the corresponding Z Benefit package rate.

How to Avail of the Benefit

The Z Benefit Package for breast cancer is available exclusively through contracted health facilities. As of the announcement, 21 facilities were contracted to provide the benefit, including East Avenue Medical Center in Quezon City and the Philippine General Hospital in Manila among those in Metro Manila.

Members or their qualified dependents must coordinate directly with the Z Benefits Coordinator at any of these contracted facilities. The coordinator handles pre-authorization procedures, document preparation, and coordination with PhilHealth for claims reimbursement.

PhilHealth has encouraged more qualified hospitals and health facilities to enter into contracts to provide this benefit, with the goal of expanding geographic access to treatment.

The Larger Picture

The enhancement of the breast cancer Z Benefit Package is part of a broader wave of PhilHealth benefit increases implemented in 2024. These include a 30% inflation adjustment across most existing case rates, as well as targeted increases for catastrophic conditions such as ischemic stroke, hemorrhagic stroke, high-risk pneumonia, and kidney disease.

For breast cancer specifically, the increase is particularly significant because targeted therapy, the treatment most responsible for improved survival outcomes in HER2-positive and other breast cancer subtypes, was essentially inaccessible to most PhilHealth members under the old package.

Ledesma expressed hope that the enhanced benefit would have a ripple effect on the broader healthcare system, improving both access to treatment and outcomes for Filipino women diagnosed with the disease.

The APMARGIN Perspective

The PHP 1.4 million Z Benefit Package represents a substantive policy improvement. It acknowledges what cancer care actually costs and moves PhilHealth closer to its mandate as a genuine financial protection mechanism.

But the benefit can only reach patients who get diagnosed. Out of 54 million Filipino women, only around 540,000 are tested for breast and cervical cancer annually, a screening rate that remains among the lowest in the world.

The enhanced Z Benefit addresses what happens after diagnosis. The more urgent structural problem is ensuring that diagnosis happens early enough for treatment to be effective. Expanding contracted facility networks, particularly outside Metro Manila, and integrating breast cancer screening into primary care are the logical next steps to making this benefit meaningful for the women who need it most.

References

• PhilHealth. Breast cancer benefit now up to Php 1.4 million. PhilHealth Official News. April 6, 2024.
• PhilHealth Circular No. 2024-0007: Z Benefits Package for Breast Cancer. March 30, 2024.
• Philippine Daily Inquirer. PhilHealth breast cancer coverage now at P1.4 million. March 2024.
• Philippine News Agency. PhilHealth hikes Z benefit for breast cancer patients to P1.4M. 2024.
• International Agency for Research on Cancer. GLOBOCAN 2022 Philippines Fact Sheet.
• Ho G, et al. Survival of Filipino women with breast cancer in the United States. PMC. 2023.
• Ho G, et al. Breast and cervical cancer screening in the Philippines: Challenges and steps forward. ScienceDirect. 2022.
• Center of Women’s Resources. Ulat Lila 2025: Report on the Situation of Filipino Women. 2025.
• Philippine Institute for Development Studies. Only 1% of Filipino Women Get Tested for Breast Cancer. PIDS News. April 2025.
• Lacson JCA, et al. Young Filipino breast cancer patients have worse survival outcomes. ecancer. 2024.